315 related articles for article (PubMed ID: 35978510)
1. Autoimmune inflammatory rheumatic diseases post-COVID-19 vaccination.
Safary A; Esalatmanesh K; Eftekharsadat AT; Jafari Nakjavani MR; Khabbazi A
Int Immunopharmacol; 2022 Sep; 110():109061. PubMed ID: 35978510
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of the mRNA-1273 and ChAdOx1 nCoV-19 vaccines in Asian patients with autoimmune rheumatic diseases under biologic and/or conventional immunosuppressant treatments.
Liao HT; Tung HY; Chou CT; Tsai HC; Yen YN; Tsai CY
Scand J Rheumatol; 2022 Nov; 51(6):500-505. PubMed ID: 35638589
[TBL] [Abstract][Full Text] [Related]
3. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
Machado PM; Lawson-Tovey S; Strangfeld A; Mateus EF; Hyrich KL; Gossec L; Carmona L; Rodrigues A; Raffeiner B; Duarte C; Hachulla E; Veillard E; Strakova E; Burmester GR; Yardımcı GK; Gomez-Puerta JA; Zepa J; Kearsley-Fleet L; Trefond L; Cunha M; Mosca M; Cornalba M; Soubrier M; Roux N; Brocq O; Durez P; Conway R; Goulenok T; Bijlsma JW; McInnes IB; Mariette X
Ann Rheum Dis; 2022 May; 81(5):695-709. PubMed ID: 34972811
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology.
Park JK; Lee EB; Shin K; Sung YK; Kim TH; Kwon SR; Lee MS; Hong SJ; Choi BY; Lee SS; Back HJ;
J Korean Med Sci; 2021 Mar; 36(12):e95. PubMed ID: 33783147
[TBL] [Abstract][Full Text] [Related]
5. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review.
Joudeh AI; Lutf AQ; Mahdi S; Tran G
Vaccine; 2023 Jun; 41(26):3801-3812. PubMed ID: 37244811
[TBL] [Abstract][Full Text] [Related]
7. Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series.
Furer V; Zisman D; Kibari A; Rimar D; Paran Y; Elkayam O
Rheumatology (Oxford); 2021 Oct; 60(SI):SI90-SI95. PubMed ID: 33848321
[TBL] [Abstract][Full Text] [Related]
8. Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination.
Kim JW; Jung JY; Suh CH; Ye YM; Kim HA
J Korean Med Sci; 2023 Aug; 38(32):e247. PubMed ID: 37582497
[TBL] [Abstract][Full Text] [Related]
9. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series.
Metyas S; Chen C; Aung T; Ballester A; Cheav S
Curr Rheumatol Rev; 2022; 18(4):346-351. PubMed ID: 35152867
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.
Naveen R; Nikiphorou E; Joshi M; Sen P; Lindblom J; Agarwal V; Lilleker JB; Tan AL; Salim B; Ziade N; Velikova T; Gracia-Ramos AE; Kuwana M; Day J; Makol A; Distler O; Chinoy H; Traboco LS; Wibowo SAK; Tehozol EAZ; Serrano JR; García-De La Torre I; ; Aggarwal R; Gupta L; Agarwal V; Parodis I
Rheumatology (Oxford); 2023 Jul; 62(7):2453-2463. PubMed ID: 36413073
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.
Furer V; Eviatar T; Zisman D; Peleg H; Paran D; Levartovsky D; Zisapel M; Elalouf O; Kaufman I; Meidan R; Broyde A; Polachek A; Wollman J; Litinsky I; Meridor K; Nochomovitz H; Silberman A; Rosenberg D; Feld J; Haddad A; Gazzit T; Elias M; Higazi N; Kharouf F; Shefer G; Sharon O; Pel S; Nevo S; Elkayam O
Ann Rheum Dis; 2021 Oct; 80(10):1330-1338. PubMed ID: 34127481
[TBL] [Abstract][Full Text] [Related]
12. New-onset autoimmune phenomena post-COVID-19 vaccination.
Chen Y; Xu Z; Wang P; Li XM; Shuai ZW; Ye DQ; Pan HF
Immunology; 2022 Apr; 165(4):386-401. PubMed ID: 34957554
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?
Jara LJ; Vera-Lastra O; Mahroum N; Pineda C; Shoenfeld Y
Clin Rheumatol; 2022 May; 41(5):1603-1609. PubMed ID: 35378658
[TBL] [Abstract][Full Text] [Related]
14. Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients.
An Z; Figueroa-Parra G; Zhou X; Li Y; Jaquith J; McCarthy-Fruin K; Sletten J; Warrington KJ; Weyand C; Crowson CS; Chumsri S; Knutson KL; Sanchez-Rodriguez A; Thanarajasingam U; Duarte-García A; Zeng H
Front Immunol; 2023; 14():1224702. PubMed ID: 37583697
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
16. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases.
Aikawa NE; Kupa LVK; Medeiros-Ribeiro AC; Saad CGS; Yuki EFN; Pasoto SG; Rojo PT; Pereira RMR; Shinjo SK; Sampaio-Barros PD; Andrade DCO; Halpern ASR; Fuller R; Souza FHC; Guedes LKN; Assad APL; Moraes JCB; Lopes MRU; Martins VAO; Betancourt L; Ribeiro CT; Sales LP; Bertoglio IM; Bonoldi VLN; Mello RLP; Balbi GGM; Sartori AMC; Antonangelo L; Silva CA; Bonfa E
Ann Rheum Dis; 2022 Jul; 81(7):1036-1043. PubMed ID: 35277389
[TBL] [Abstract][Full Text] [Related]
17. Attitudes and factors affecting decision-making regarding COVID-19 vaccination among autoimmune rheumatic disease patients.
Wantha O; Mahakkanukrauh A; Tuydaung K; Donsrichan W; Yingyaun K; Kaewmeun S; Suwannaroj S; Foocharoen C
Int J Rheum Dis; 2023 Apr; 26(4):751-758. PubMed ID: 36872073
[TBL] [Abstract][Full Text] [Related]
18. Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort.
Zecca E; Rizzi M; Tonello S; Matino E; Costanzo M; Rizzi E; Casciaro GF; Manfredi GF; Acquaviva A; Gagliardi I; Calzaducca E; Mallela VR; D'Onghia D; Minisini R; Bellan M; Castello LM; Gavelli F; Avanzi GC; Patrucco F; Chiocchetti A; Pirisi M; Rigamonti C; Lilleri D; Sola D; Sainaghi PP
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016388
[TBL] [Abstract][Full Text] [Related]
19. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.
Sattui SE; Liew JW; Kennedy K; Sirotich E; Putman M; Moni TT; Akpabio A; Alpízar-Rodríguez D; Berenbaum F; Bulina I; Conway R; Singh AD; Duff E; Durrant KL; Gheita TA; Hill CL; Howard RA; Hoyer BF; Hsieh E; El Kibbi L; Kilian A; Kim AH; Liew DFL; Lo C; Miller B; Mingolla S; Nudel M; Palmerlee CA; Singh JA; Singh N; Ugarte-Gil MF; Wallace J; Young KJ; Bhana S; Costello W; Grainger R; Machado PM; Robinson PC; Sufka P; Wallace ZS; Yazdany J; Harrison C; Larché M; Levine M; Foster G; Thabane L; Rider LG; Hausmann JS; Simard JF; Sparks JA
RMD Open; 2021 Sep; 7(3):. PubMed ID: 34493645
[TBL] [Abstract][Full Text] [Related]
20. Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition.
Silva CA; de Vinci Kanda Kupa L; Medeiros-Ribeiro AC; Pasoto SG; Saad CGS; Yuki EFN; Landim JIVD; Léda VHFE; de Camargo Correia LS; Sartori AF; Martins CCMF; Ribeiro CT; Waridel F; de Oliveira Martins VA; Shinjo SK; Andrade DCO; Sampaio-Barros PD; Neto EFB; Aikawa NE; Bonfa E
Adv Rheumatol; 2023 Jun; 63(1):26. PubMed ID: 37291679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
